Get the Stockscreener App
3.45
1.43%
-0.05
Galectin Therapeutics Inc Stock (GALT) Forecast
The Galectin Therapeutics Inc (GALT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.5294, representing a -26.68% decrease from the current price of $3.45. The highest analyst price target is $3.0612, and the lowest is $1.9977.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GALT Price Target
Average 1.634
(-52.64% Downside)
Is Galectin Therapeutics Inc (GALT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 57.74 | Neutral |
| STOCH(9,6) | 35.06 | Neutral |
| STOCHRSI(14) | 18.00 | Buy |
| MACD(12,26) | 0.2327 | Sell |
| ADX(14) | 44.86 | Buy |
| William %R | -58.95 | Neutral |
| CCI(14) | -6.6389 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.412
Buy
|
3.4084
Buy
|
| MA20 |
3.416
Buy
|
3.274
Buy
|
| MA50 |
2.5957
Buy
|
2.7946
Buy
|
| MA100 |
2.1694
Buy
|
2.4157
Buy
|
| MA200 |
1.9953
Buy
|
2.122
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, GALT could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 1 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on GALT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 57.74 indicates that GALT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.06 indicates that GALT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 18 indicates that GALT is oversold. This suggests that GALT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 44.86 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -6.6389 indicates that GALT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term GALT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Galectin Therapeutics Inc financial reports and earnings history, Galectin Therapeutics Inc (GALT) stock could reach $1.1424 by 2030, $1.3201 by 2040 and $4.7453 by 2050. See the projected annual prices until 2050 of the Galectin Therapeutics Inc stock below:
- Galectin Therapeutics Inc (GALT) is expected to reach an average price of $0.0325 in 2035, with a high prediction of $0.3011 and a low estimate of $0.00251. This indicates an $-99.06% rise from the last recorded price of $3.45.
- Galectin Therapeutics Inc (GALT) stock is projected to chart a bullish course in 2040, with an average price target of $1.3394, representing an $-61.18% surge from its current level. The forecast ranges from a conservative $1.3215 to a sky-high $1.3201.
- Our analysts predict Galectin Therapeutics Inc (GALT) to jump -13.52% by 2045, soaring from $2.8204 to an average price of $2.9835, potentially reaching $2.8935. While $2.8204 is the low estimate, the potential upside is significant.
- Galectin Therapeutics Inc (GALT) stock is expected to climb by 2050, reaching an average of $4.5697, a $32.46% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.7453 and $4.7697, respectively, highlighting the market's uncertainty.
Galectin Therapeutics Inc Stock (GALT) Year by Year Forecast
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2024
Our forecast for GALT stock price in 2024 now indicates an average price target of $2.5972 with a high forecast of $4.1056 and a low forecast of $1.0889. The average prediction reflects an decrease of -24.72% from the last recorded price of $3.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $2.7352 | $1.9977 | $3.0612 | -20.72% |
| June, 2024 | $2.1326 | $1.9126 | $3.0624 | -38.19% |
| July, 2024 | $2.0473 | $1.6597 | $2.3268 | -40.66% |
| August, 2024 | $1.8996 | $1.8111 | $2.2039 | -44.94% |
| September, 2024 | $1.4524 | $1.0889 | $1.9517 | -57.90% |
| October, 2024 | $1.7717 | $1.346 | $2.1231 | -48.65% |
| November, 2024 | $2.0309 | $1.7602 | $2.4874 | -41.13% |
| December, 2024 | $1.4437 | $1.3587 | $2.6987 | -58.15% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2025
Galectin Therapeutics Inc Stock (GALT) is expected to reach an average price of $1.134 in 2025, with a high prediction of $2.2303 and a low estimate of $0.0377. This indicates an -67.13% fall from the last recorded price of $3.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.093 | $0.963 | $1.5058 | -68.32% |
| February, 2025 | $1.1172 | $0.9365 | $1.3501 | -67.62% |
| March, 2025 | $0.865 | $0.765 | $1.3043 | -74.93% |
| April, 2025 | $0.5793 | $0.2057 | $1.1486 | -83.21% |
| May, 2025 | $0.2235 | $0.0501 | $0.5327 | -93.52% |
| June, 2025 | $0.7763 | $0.0377 | $1.8413 | -77.50% |
| July, 2025 | $1.4355 | $0.6436 | $1.4455 | -58.39% |
| August, 2025 | $1.1798 | $0.9079 | $1.5091 | -65.80% |
| September, 2025 | $1.1676 | $0.8733 | $1.5869 | -66.16% |
| October, 2025 | $1.4268 | $0.8183 | $1.5518 | -58.64% |
| November, 2025 | $1.0161 | $0.8861 | $1.6054 | -70.55% |
| December, 2025 | $1.0139 | $0.7968 | $2.2303 | -70.61% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2026
The predicted value for Galectin Therapeutics Inc (GALT) in 2026 is set at an average of $2.2329. Estimates vary from a peak of $4.1978 to a trough of $0.268, indicating an -35.28% surge from the present price of $3.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.9381 | $0.8481 | $1.431 | -72.81% |
| February, 2026 | $1.0624 | $0.8918 | $1.2552 | -69.21% |
| March, 2026 | $0.8502 | $0.7166 | $1.3029 | -75.36% |
| April, 2026 | $0.6144 | $0.5583 | $0.8687 | -82.19% |
| May, 2026 | $0.8087 | $0.268 | $1.1251 | -76.56% |
| June, 2026 | $0.6265 | $0.4958 | $0.9729 | -81.84% |
| July, 2026 | $0.6807 | $0.4971 | $1.7571 | -80.27% |
| August, 2026 | $2.7585 | $0.9443 | $4.1978 | -20.04% |
| September, 2026 | $1.6427 | $1.6027 | $2.8421 | -52.38% |
| October, 2026 | $1.987 | $1.187 | $2.937 | -42.41% |
| November, 2026 | $1.9348 | $1.0606 | $2.1448 | -43.92% |
| December, 2026 | $2.419 | $1.7384 | $2.699 | -29.88% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Galectin Therapeutics Inc (GALT) is $1.4102, with a high forecast of $2.8197 and a low forecast of $0.000726. This indicates an -59.12% decrease from the last price of $3.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.4833 | $2.1863 | $2.8197 | -28.02% |
| February, 2027 | $1.8875 | $1.7075 | $2.5664 | -45.29% |
| March, 2027 | $1.1853 | $1.0953 | $1.9746 | -65.64% |
| April, 2027 | $1.0096 | $0.6996 | $1.2989 | -70.74% |
| May, 2027 | $0.5674 | $0.5574 | $1.1067 | -83.55% |
| June, 2027 | $0.7416 | $0.3609 | $0.8616 | -78.50% |
| July, 2027 | $0.4909 | $0.4259 | $0.8152 | -85.77% |
| August, 2027 | $0.2737 | $0.2737 | $0.633 | -92.07% |
| September, 2027 | $0.2579 | $0.1679 | $0.4708 | -92.52% |
| October, 2027 | $0.0422 | $0.00533 | $0.3615 | -98.78% |
| November, 2027 | $0.000044 | $0.000726 | $0.4793 | -100.00% |
| December, 2027 | $0.4042 | $0.0301 | $0.6142 | -88.28% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2028
In 2028, Galectin Therapeutics Inc (GALT) is projected to reach an average price of $0.6825, with a high projection of $1.3595 and a low estimate of $0.00541. This indicates an -80.22% fall from the last price of $3.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.772 | $0.3678 | $1.3313 | -77.62% |
| February, 2028 | $0.5962 | $0.4262 | $0.8556 | -82.72% |
| March, 2028 | $0.3505 | $0.2769 | $0.6898 | -89.84% |
| April, 2028 | $0.1947 | $0.1512 | $0.514 | -94.36% |
| May, 2028 | $0.1025 | $0.00541 | $0.2583 | -97.03% |
| June, 2028 | $0.0668 | $0.0261 | $0.1773 | -98.06% |
| July, 2028 | $0.0254 | $0.029 | $0.0739 | -99.26% |
| August, 2028 | $0.4288 | $0.0217 | $0.7653 | -87.57% |
| September, 2028 | $0.7631 | $0.4424 | $1.3595 | -77.88% |
| October, 2028 | $0.9209 | $0.6866 | $1.1638 | -73.31% |
| November, 2028 | $0.6151 | $0.5416 | $0.9644 | -82.17% |
| December, 2028 | $0.5094 | $0.4458 | $0.8422 | -85.24% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2029
The 2029 price forecast for Galectin Therapeutics Inc Stock (GALT) is $1.1063 on average, with a high prediction of $2.1512 and a low estimate of $0.0614. This represents an -67.93% decrease from the previous price of $3.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4172 | $0.23 | $0.5619 | -87.91% |
| February, 2029 | $0.4714 | $0.4007 | $0.9443 | -86.34% |
| March, 2029 | $0.6383 | $0.325 | $0.7356 | -81.50% |
| April, 2029 | $0.7535 | $0.6228 | $0.9999 | -78.16% |
| May, 2029 | $1.0577 | $0.777 | $1.2906 | -69.34% |
| June, 2029 | $1.1319 | $0.9748 | $1.1319 | -67.19% |
| July, 2029 | $0.9497 | $0.8355 | $1.1591 | -72.47% |
| August, 2029 | $0.5429 | $0.6129 | $0.9332 | -84.26% |
| September, 2029 | $0.8956 | $0.0614 | $1.0085 | -74.04% |
| October, 2029 | $1.7212 | $0.1341 | $2.1512 | -50.11% |
| November, 2029 | $0.8197 | $0.2617 | $2.0583 | -76.24% |
| December, 2029 | $0.4853 | $0.0753 | $1.3311 | -85.93% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2030
Galectin Therapeutics Inc Stock (GALT) is expected to reach an average price of $0.6076 in 2030, with a high forecast of $1.2045 and a low forecast of $0.0107. This signifies an -82.39% decrease from the last price of $3.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.7288 | $0.2724 | $1.1424 | -78.88% |
| February, 2030 | $0.2123 | $0.0152 | $1.1578 | -93.85% |
| March, 2030 | $0.1677 | $0.0436 | $0.4436 | -95.14% |
| April, 2030 | $0.3886 | $0.0107 | $0.3279 | -88.74% |
| May, 2030 | $0.3951 | $0.5494 | $0.2551 | -88.55% |
| June, 2030 | $0.0617 | $0.1909 | $0.2862 | -98.21% |
| July, 2030 | $0.3689 | $0.0424 | $0.749 | -89.31% |
| August, 2030 | $0.3576 | $0.2134 | $0.8974 | -89.64% |
| September, 2030 | $0.7583 | $0.5883 | $0.5936 | -78.02% |
| October, 2030 | $0.6485 | $0.6948 | $0.6332 | -81.20% |
| November, 2030 | $0.89 | $0.6513 | $0.85 | -74.20% |
| December, 2030 | $1.5694 | $0.9857 | $1.2045 | -54.51% |
1.53%
3.38%
Cap:
|
Volume (24h):